FILTRIX Logo FILTRIX Find Your Edge →
Ticker Report — Active Last signal ·

$CHRS

Trade-Ideas alert history 47 alerts 2022-01-122025-01-24

⚠ SMALL SAMPLE · 47 alerts only. Statistics may have high variance — interpret with caution.

🏢 Company Profile

📍 NASDAQ 📅 IPO: Nov 06, 2014 🔗 www.coherus.com
💰 Market Cap: $263.8M 👥 Employees: 147
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.
Total alerts
47
Trade-Ideas signal history
Win rate · 60MIN
48.9%
Best timeframe baseline
Avg gain · 60MIN
-0.62%
Per-alert expectancy
Avg MFE
+6.39%
Max potential excursion

Practice trading CHRS on historical setups — browse all patterns across all tickers →

📈 Performance by Timeframe

5MIN

Win Rate: 46.8%
Avg Gain: -0.37%
Avg Winner: +2.33%
Avg Loser: -2.76%
Best: +5.61%
Worst: -7.01%
Trades: 22/25

15MIN

Win Rate: 38.3%
Avg Gain: -0.80%
Avg Winner: +3.70%
Avg Loser: -3.73%
Best: +13.64%
Worst: -8.61%
Trades: 18/28

30MIN

Win Rate: 40.4%
Avg Gain: -0.36%
Avg Winner: +4.35%
Avg Loser: -3.69%
Best: +13.58%
Worst: -13.67%
Trades: 19/27

60MIN

Win Rate: 48.9%
Avg Gain: -0.62%
Avg Winner: +4.35%
Avg Loser: -5.61%
Best: +15.66%
Worst: -17.41%
Trades: 23/23

EOD (End of Day)

Win Rate: 36.2%
Avg Gain: -2.11%
Avg Winner: +7.24%
Avg Loser: -7.67%
Best: +22.26%
Worst: -22.33%
Trades: 17/29

🚀 Max Favorable / Adverse Excursion (MFE/MAE)

Institutional-grade metrics showing the maximum profit potential and risk for each alert.

📈 MFE (Max Profit Potential)

Average MFE: +6.39%
Best MFE: +25.65%
Avg Time to MFE: 84 min

On average, CHRS alerts reach +6.39% profit potential within 84 minutes.

📉 MAE (Max Drawdown Risk)

Average MAE: -2.85%
Worst MAE: -17.76%
Avg Time to MAE: 7 min

Before reaching MFE, expect an average drawdown of 2.85%.

⚖️ Risk/Reward Ratio

2.24:1

Excellent risk/reward - potential gain is 2.24x the typical drawdown.

💡 Trading Insight: Based on 47 alerts, CHRS typically reaches +6.39% profit before pulling back. Consider setting profit targets around 5.1% to capture most of the move.

🌅 Premarket Gap Analysis (9:25 → 9:30)

Total Gaps Analyzed 47
Gap Up % 38.3%
Avg Gap -0.22%
Best Gap +2.36%

🏭 Sector Comparison: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

How CHRS compares to 128 other tickers in the same sector.

5-Min Gain
CHRS: -0.37% Sector: -0.41% +0.04%
EOD Gain
CHRS: -2.11% Sector: +1233.50% -1235.62%
Avg MFE
CHRS: +6.39% Sector: +6.69% -0.30%

📋 Last 20 Alerts

Historical CHRS alerts with performance metrics calculated from 1-minute price data. Each row shows the actual price movement at different timeframes after the alert.

Date Time Price 5min 15min 30min 60min EOD MFE MAE Gap Result
2025-01-24 09:26:17 $1.36 -1.84% -2.21% -1.10% +0.10% -8.82% +1.51% -3.67% -1.47% LOSS
2024-12-10 09:29:20 $1.72 -1.08% -1.74% -0.29% -2.03% -6.40% - -2.33% -1.16% LOSS
2024-12-09 09:28:29 $1.76 +0.56% +0.67% +1.99% +2.84% -3.41% +5.11% -3.41% +1.14% WIN
2024-12-06 09:28:16 $1.52 -1.32% +0.33% +2.96% +2.96% +11.84% +14.47% -4.61% -1.97% LOSS
2024-12-05 09:26:44 $1.8 -3.06% -3.06% -3.89% -5.83% -16.11% - - - LOSS
2024-12-04 09:27:18 $1.78 +5.61% - -0.28% - -3.93% +9.55% -4.78% +2.25% WIN
2024-12-03 09:25:53 $2.14 -7.01% -1.87% +9.81% -6.50% -20.09% +13.55% -17.76% -4.67% LOSS
2024-11-21 09:25:49 $1.07 +1.87% -3.93% -3.74% +0.92% +2.80% +9.35% -5.61% - WIN
2024-11-08 09:26:59 $0.82 +2.67% -2.57% -2.73% -2.40% -0.54% +4.94% +1.29% +1.29% WIN
2024-11-07 09:27:40 $0.78 +5.23% +4.08% +7.49% +10.20% +4.59% +21.81% -2.93% +1.52% WIN
2024-10-04 09:27:05 $1.0 +2.00% -1.89% -1.11% +3.00% +4.00% +8.00% -1.98% -1.00% WIN
2024-10-03 09:29:40 $1.05 -3.80% -3.71% +7.62% +3.81% -0.95% +17.14% -3.81% -2.86% LOSS
2024-06-27 09:29:42 $1.69 +1.48% +3.56% +1.48% +2.01% +0.59% +4.14% -1.18% +0.59% WIN
2024-03-04 09:29:38 $2.56 -6.25% -7.43% -9.18% -11.13% -11.33% -0.78% -5.86% -0.78% LOSS
2024-02-20 09:25:08 $2.68 +0.37% +0.41% +1.49% +3.17% -3.36% +3.73% -0.37% - WIN
2024-02-13 09:27:34 $2.54 +2.76% +4.33% +2.76% +3.35% +0.79% +5.88% -1.57% +2.36% WIN
2023-12-29 09:28:00 $3.33 +0.30% -2.70% -2.23% -3.00% - +2.40% -5.71% -0.60% WIN
2023-12-28 09:28:00 $2.65 +3.24% +11.13% +13.58% +15.66% +22.26% +25.65% -3.02% - WIN
2023-12-27 09:25:00 $2.96 -0.67% -7.94% -8.10% -9.63% -9.12% +3.04% -3.04% +1.35% LOSS
2023-12-08 09:28:00 $2.15 -2.83% +1.16% +2.09% +3.95% +3.26% +6.98% -4.18% +0.47% LOSS

Table Metrics Explained:

  • 5min/15min/30min/60min/EOD: Price change at each timeframe (calculated from real minute-by-minute data)
  • MFE: Maximum Favorable Excursion - highest profit potential reached during the day
  • MAE: Maximum Adverse Excursion - worst drawdown experienced before reaching MFE
  • Gap: Premarket price gap from 9:25 AM to 9:30 AM market open
  • Result: WIN if 5min change > 0%, LOSS otherwise

⚠ CHRS Shows Negative Expectancy

With 48.9% win rate and -0.62% average gain, CHRS alerts have historically faded. Use the app to find specific filters that might reverse this pattern, or consider CHRS for short-selling strategies.

📉 Turn Negative Expectancy Positive →

Why Analyze CHRS with FILTRIX?

🛡️ Realistic Entry Simulation

We don't inflate stats. Our analysis tracks only the first alert of the day for CHRS. This simulates a true "Gap & Go" entry at pre-market hours (9:25-9:30 AM), avoiding the trap of chasing a stock that has already extended.

💰 Max Potential (MFE) Analysis

How much is left in the move? On winning days, CHRS historically offers an average upside of +6.39% intraday. Our data helps you distinguish between a quick scalp and a runner.

📊 CHRS Momentum Personality

With a baseline win rate of 48.9%, CHRS shows negative momentum - the stock tends to fade after alerts. This pattern suggests CHRS may be better suited for contrarian strategies or avoiding altogether.

⏱️ Optimized Exit Timing

⚠️ Caution Advised: CHRS shows negative expectancy across all tested intraday timeframes (Best: 60MIN at -0.62%). This suggests CHRS is prone to fading after the open, making it a potential candidate for short-selling or quick scalps only.